AstraZeneca Pharma India has entered into an exclusive distribution agreement with New Delhi- based Mankind Pharma for its budesonide and formoterol fumarate dihydrate (inhaled corticosteroid and long-acting beta-agonist combination) brand Symbicort in India. Under the agreement, AstraZeneca will retain intellectual property rights and remain the Marketing Authorization Holder and...